Information on biocides
Information on biocides
Information on biocides
Il-prinċipju bażiku fir-Regolament dwar il-Prodotti Bijoċidali ((UE) Nru 528/2012 (BPR)) huwa li prodott bijoċidali għandu jiġi awtorizzat qabel ma jkun jista’ jitqiegħed fis-suq jew jintuża fiż-Żona Ekonomika Ewropea (ŻEE) u fl-Iżvizzera. Dan iseħħ f’żewġ stadji konsekuttivi. L-ewwel nett, is-sustanza attiva tiġi evalwata u, dment li jiġu ssodisfati l-kriterji, imbagħad tiġi approvata f’tip ta’ prodott speċifikat. It-tieni stadju huwa l-awtorizzazzjoni ta’ kull prodott li jikkonsisti fi, li jkun fih jew li jiġġenera s-sustanza(i) attiva(i) approvata(i). Din il-paġna tikkonċerna l-ewwel stadju.
Id-data f’din il-paġna hija ċċentrata fuq is-sustanza attiva/it-tip ta’ prodott. Dan huwa rifless fil-filtri tat-tiftix kollha u r-riżultati tat-tfittxijiet. Sussegwentement, it-tabella ta’ hawn taħt turi informazzjoni għal kull kombinazzjoni ta’ sustanza attiva/tip ta’ prodott. Għal raġunijiet ta’ effiċjenza, it-terminu sustanza attiva jintuża interkambjabbli mat-terminu ta’ kombinazzjoni ta’ sustanza attiva/tip ta’ prodott.
Il-bażi tad-data tinkludi sustanzi attivi fil-Programm ta’ Reviżjoni, sustanzi attivi mhux fil-Programm ta’ Reviżjoni kif ukoll sustanzi fl-Anness I għall-BPR. Aktar informazzjoni dwar il-kategorizzazzjoni ta’ sustanzi attivi tista’ tinqara fil-paġna Approvazzjoni ta’ sustanzi attivi.
Għal aktar informazzjoni dwar it-tfittxijiet li tista’ twettaq u kif l-informazzjoni hija ppreżentata jekk jogħġbok kompli aqra.
Kif għandek tfittex
Tista’ tara l-informazzjoni dwar is-sustanzi attivi bijoċidali b’żewġ modi:
- għal kull kombinazzjoni speċifika ta’ sustanza attiva u tip ta’ prodott (uża t-tab Fittex); u
- bħala sommarju tal-applikazzjonijiet kollha tat-tip ta’ prodott li ġew sottomessi għal sustanza attiva partikolari (tab tas-Sommarju).
Billi tuża t-tab Fittex, tista’ tfittex bi:
- Dettalji tas-sustanza attiva: identifikaturi tas-sustanza, tip ta’ prodott, kandidat għal sostituzzjoni.
(L-istatus prestabbilit għall-qasam Kandidat għal sostituzzjoni huwa “taħt valutazzjoni” u dan l-istatus mhux neċessarjament jimplika li s-sustanza attiva hija suspettata Kandidat għal sostituzzjoni. Sakemm is-sustanza attiva tkun identifikata jew le bħala kandidat potenzjali għal sostituzzjoni, l-istatus fuq il-paġna ta’ disseminazzjoni jinbidel kif meħtieġ għal “iva” jew “le”.)
- Data tal-approvazzjoni: pereżempju l-istatus ta’ applikazzjoni għall-approvazzjoni, l-istadju tal-valutazzjoni fil-proċess tal-approvazzjoni, il-validità tal-approvazzjoni mogħtija.
- Prodotti bijoċidali awtorizzati relatati (isem kummerċjali ta’ prodott bijoċidali).
Kif tiġi ppreżentata l-informazzjoni
It-tabella tar-riżultati tippreżenta informazzjoni dwar sustanza attiva, bħad-data tal-bidu u tat-tmiem tal-approvazzjoni, l-awtorità kompetenti tal-evalwazzjoni u l-istatus tal-approvazzjoni jew tal-valutazzjoni. L-isem tas-sustanza huwa link għall-paġna tal-informazzjoni dwar is-sustanza (Infocard) li tiġbor fil-qosor l-informazzjoni dwar sustanza mill-kuntesti regolatorji kollha ġestiti mill-ECHA.
Id-data dwar is-sustanzi attivi tinġabar mir-Reġistru għall-Prodotti Bijoċidali (R4BP 3). Din tkopri l-informazzjoni dwar is-sustanzi attivi li għalihom ġiet ippreżentata applikazzjoni għall-approvazzjoni għal tip ta’ prodott bijoċidali speċifiku skont il-BPR jew id-Direttiva dwar il-Prodotti Bijoċidali (id-Direttiva 98/8/KE). Jekk jogħġbok kun af li l-istadju ta’ validazzjoni f’R4BP 3 għandu jgħaddi b’suċċess biex is-sustanzi attivi jiġu diffużi jew biex jintwera l-istatus l-aktar reċenti fil-proċess tal-applikazzjoni.
Aktar informazzjoni dwar approvazzjoni ta’ sustanza attiva speċifika tista’ tinstab fl-iskeda informattiva (aċċessibbli permezz tal-ikona tal-għajn fit-tabella tar-riżultati). L-iskeda informattiva fiha dettalji dwar d-data tal-approvazzjoni l-aktar reċenti, inklużi d-dokumenti rilevanti, il-prodotti bijoċidali awtorizzati relatati, u ħarsa ġenerali lejn il-bidliet kollha dwar l-approvazzjoni tas-sustanza attiva.
Fit-tabella tar-riżultati, in-numru ta’ prodotti bijoċidali awtorizzati relatati huwa viżibbli wkoll. In-numru jirrappreżenta l-għadd ta’ raggruppamenti ta’ prodotti (gruppi ta’ awtorizzazzjonijiet) li fihom is-sustanza attiva partikolari.
It-tab tas-Sommarju telenka l-applikazzjonijiet kollha tat-tip ta’ prodott li ġew sottomessi għal sustanza attiva partikolari, irrispettivament minn jekk l-approvazzjoni ngħatatx jew ġiet rifjutata. L-istatus tal-approvazzjoni ta’ kombinazzjoni ta’ sustanza attiva u tip ta’ prodott huwa deskritt b’ikona. Meta tmexxi l-maws tiegħek fuq l-ikona, tista’ tara l-istatus ta’ applikazzjoni għall-approvazzjoni, l-istadju tal-valutazzjoni jekk il-proċess tal-approvazzjoni jkun għadu għaddej, u tista’ taċċessa l-iskeda informattiva tas-sustanza attiva.
Esporta r-riżultati
Tista’ tesporta r-riżultati tas-sustanza attiva lejn il-formati standard tas-sit web tal-ECHA (XLS, CSV u XML).
Due to a technical problem, which is being fixed, certain substance/product-type combinations are currently displayed with an inaccurate status.
Further information
- List of approved active substances
- Approval of active substances
- Understanding the BPR Regulation
- Q&A on Biocidal Products Regulation
- Give us your feedback
- BPC opinions on approval of active substances
- Public consultation on potential candidates for substitution
- Lists of Member States where wood treated with creosote may be placed on the market for certain uses [EN][PDF]
Summary of status of applications for approval of active substance/product-type and Annex I records under the BPD or the BPR.
Annex I | Product-type | ||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Disinfectants | Preservatives | Pest Control | Other | ||||||||||||||||||||||
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | ||||
Annex I substance (+)-Tartaric acid | 201-766-0 | 87-69-4 | Approved | ||||||||||||||||||||||
(1,3,4,5,6,7-hexahydro-1,3-dioxo-2H-isoindol-2-yl)methyl (1R-trans)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclo-propanecarboxylate (d-Tetramethrin) | 214-619-0 | 1166-46-7 | Initial application for approval in progress | ||||||||||||||||||||||
(13Z)-Hexadec-13-en-11-yn-1-yl acetate | 642-968-2 | 78617-58-0 | Approved | ||||||||||||||||||||||
(2R,6aS,12aS)-1,2,6,6a,12,12a-hexa- hydro-2-isopropenyl-8,9-dimethoxychro- meno[3,4-b]furo[2,3-h]chromen-6-one (Rotenone) | 201-501-9 | 83-79-4 | Cancelled application | ||||||||||||||||||||||
(9Z,12E)-Tetradeca-9, 12-dien-1-yl acetate | 608-490-3 | 30507-70-1 | No longer supported | ||||||||||||||||||||||
Annex I substance (9Z,12E)-tetradeca-9,12-dien-1-yl acetate | 608-490-3 | 30507-70-1 | Approved | ||||||||||||||||||||||
(benzothiazol-2-ylthio)methyl thiocyanate (TCMTB) | 244-445-0 | 21564-17-0 | Initial application for approval in progress | Initial application for approval in progress | |||||||||||||||||||||
(benzyloxy)methanol | 238-588-8 | 14548-60-8 | Initial application for approval in progress | No longer supported | |||||||||||||||||||||
(E)-1-(2-Chloro-1,3-thiazol-5-ylmethyl)-3- methyl-2-nitroguanidine (Clothianidin) | 433-460-1 | 210880-92-5 | Expired | Approved | |||||||||||||||||||||
(ethylenedioxy)dimethanol (Reaction products of ethylene glycol with paraformaldehyde (EGForm)) | 222-720-6 | 3586-55-8 | No longer supported | Initial application for approval in progress | Initial application for approval in progress | Initial application for approval in progress | Initial application for approval in progress | ||||||||||||||||||
(RS)-3-Allyl-2-methyl-4-oxocyclopent-2- enyl (1R,3R)-2,2-dimethyl-3-(2-methyl- prop-1-enyl)-cyclopropanecarboxylate (mixture of 2 isomers 1R trans: 1R/S only 1:3) (Esbiothrin) | 807-421-6 | 260359-57-7 | Not approved | ||||||||||||||||||||||
(RS)-3-Allyl-2-methyl-4-oxocyclopent-2- enyl-(1R,3R; 1R,3S)-2,2-dimethyl-3-(2- methylprop-1-enyl)-cyclopropanecarboxy- late (mixture of 4 isomers 1R trans, 1R:1R trans, 1S: 1R cis, 1R: 1R cis,1S 4:4:1:1) (d-Allethrin) |
687-634-7 | 231937-89-6 | Not approved | ||||||||||||||||||||||
(RS)-α-cyano-3phenoxybenzyl-(1RS)-cis, trans-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate (Cypermethrin) | 257-842-9 | 52315-07-8 | Approved | Approved | |||||||||||||||||||||
1,2-benzisothiazol-3(2H)-one (BIT) | 220-120-9 | 2634-33-5 | Initial application for approval in progress | Initial application for approval in progress | Initial application for approval in progress | No longer supported | Initial application for approval in progress | Initial application for approval in progress | Initial application for approval in progress | ||||||||||||||||
1,3-bis(hydroxymethyl)-5,5-dimethylimidazolidine-2,4-dione (DMDMH) | 229-222-8 | 6440-58-0 | Initial application for approval in progress | Initial application for approval in progress | |||||||||||||||||||||
1-(3,5-dichloro-4-(1,1,2,2-tetrafluoroethoxy)phenyl)-3-(2,6-difluorobenzoyl) urea (Hexaflumuron) | 401-400-1 | 86479-06-3 | Approved | ||||||||||||||||||||||
1-[2-(allyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole (Imazalil) | 252-615-0 | 35554-44-0 | No longer supported | ||||||||||||||||||||||
1-[[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-yl]methyl]-1H-1,2,4-triazole (Propiconazole) | 262-104-4 | 60207-90-1 | Approved | Approved | Approved | ||||||||||||||||||||
1-ethynyl-2-methylpent-2-enyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate (Empenthrin) | 259-154-4 | 54406-48-3 | Not approved | ||||||||||||||||||||||
1R-trans phenothrin | 247-431-2 | 26046-85-5 | Approved | ||||||||||||||||||||||
2,2-dibromo-2-cyanoacetamide (DBNPA) | 233-539-7 | 10222-01-2 | No longer supported | Not approved | Initial application for approval in progress | Initial application for approval in progress | Initial application for approval in progress | No longer supported | |||||||||||||||||
2,2′,2′′-(hexahydro-1,3,5-triazine-1,3,5- triyl)triethanol (HHT) | 225-208-0 | 4719-04-4 | Initial application for approval in progress | Initial application for approval in progress | Initial application for approval in progress | Initial application for approval in progress | |||||||||||||||||||
2,2′-dithiobis[N-methylbenzamide] (DTBMA) | 219-768-5 | 2527-58-4 | Initial application for approval in progress | ||||||||||||||||||||||
2-(2-butoxyethoxy)ethyl 6-propylpiper-onyl ether (Piperonyl butoxide/PBO) | 200-076-7 | 51-03-6 | Approved | ||||||||||||||||||||||
2-bromo-2-(bromomethyl)pentanedinitrile (DBDCB) | 252-681-0 | 35691-65-7 | Approved | ||||||||||||||||||||||
2-Butanone, peroxide | 215-661-2 | 1338-23-4 | Not approved | Not approved | Not approved | Not approved | |||||||||||||||||||
2-butyl-benzo[d]isothiazol-3-one (BBIT)
SUBSTANCE S123386;
VANQUISH 100 |
420-590-7 | 4299-07-4 | Initial application for approval in progress | Initial application for approval in progress | Initial application for approval in progress | Initial application for approval in progress | Initial application for approval in progress | ||||||||||||||||||
2-chloro-N-[[[4-(trif luoromethoxy) phenyl]amino]carbonyl]benzamide (Triflumuron) | 264-980-3 | 64628-44-0 | Not approved | ||||||||||||||||||||||
2-hydroxy-α,α,4-trimethylcyclohexanemethanol | 255-953-7 | 42822-86-6 | No longer supported | ||||||||||||||||||||||
2-methyl-2,3-dihydro-1,2-thiazol-3-one hydrochloride | 247-499-3 | 26172-54-3 | Initial application for approval in progress | ||||||||||||||||||||||
2-methyl-2H-isothiazol-3-one (MIT) | 220-239-6 | 2682-20-4 | Initial application for approval in progress | Approved | Approved | Approved | |||||||||||||||||||
2-methyl-4-oxo-3-(prop-2-ynyl)cyclopent-2-en-1-yl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate (Prallethrin) | 245-387-9 | 23031-36-9 | Initial application for approval in progress | ||||||||||||||||||||||
2-octyl-2H-isothiazol-3-one (OIT) | 247-761-7 | 26530-20-1 | Initial application for approval in progress | Initial application for approval in progress | Approved | Initial application for approval in progress | Initial application for approval in progress | Initial application for approval in progress | Initial application for approval in progress | ||||||||||||||||
2-Phenoxyethanol | 204-589-7 | 122-99-6 | Initial application for approval in progress | Initial application for approval in progress | Not approved | Initial application for approval in progress | Cancelled application | Cancelled application | |||||||||||||||||
2-Propenoic acid, 2-methyl-, butyl ester, polymer with butyl 2-propenoate and methyl 2-methyl-2-propenoate (CAS nr: 25322-99-0)/ Polymeric quaternary ammonium bromide (PQ Polymer) | - | - | Not approved | Not approved | |||||||||||||||||||||
2-thiazol-4-yl-1H-benzoimidazole (Thiabendazole) | 205-725-8 | 148-79-8 | Initial application for approval in progress | Expired | Initial application for approval in progress | Initial application for approval in progress | |||||||||||||||||||
3-(4-isopropylphenyl)-1,1-dimethylurea/ Isoproturon | 251-835-4 | 34123-59-6 | Initial application for approval in progress | Initial application for approval in progress | |||||||||||||||||||||
3-iodo-2-propynylbutylcarbamate (IPBC) | 259-627-5 | 55406-53-6 | Approved | Initial application for approval in progress | Approved | Initial application for approval in progress | Initial application for approval in progress | Approved | |||||||||||||||||
3-phenoxybenzyl (1R)-cis,trans-2,2- dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate (d-Phenothrin) | - | 188023-86-1 | No longer supported | ||||||||||||||||||||||
4,4-dimethyloxazolidine | 257-048-2 | 51200-87-4 | Not approved | Not approved | Not approved | ||||||||||||||||||||
4,5-Dichloro-2-octylisothiazol-3(2H)-one (4,5-Dichloro-2-octyl-2H-isothiazol-3-one (DCOIT)) | 264-843-8 | 64359-81-5 | Initial application for approval in progress | Approved | Initial application for approval in progress | Initial application for approval in progress | Initial application for approval in progress | Approved | |||||||||||||||||
4-bromo-2-(4-chlorophenyl)-1-ethoxy- methyl-5-trifluoromethylpyrrole-3-carbonitrile (Chlorfenapyr) | 602-782-4 | 122453-73-0 | Approved | Initial application for approval in progress | |||||||||||||||||||||
5-chloro-2-(4-chlorphenoxy)phenol (DCPP) | 429-290-0 | 3380-30-1 | Approved | Approved | Approved | ||||||||||||||||||||
5-Chloro-2-methyl-2H-isothiazol-3-one (CIT) | 247-500-7 | 26172-55-4 | Initial application for approval in progress | ||||||||||||||||||||||
6-(phthalimido)peroxyhexanoic acid (PAP)
PAP
|
410-850-8 | 128275-31-0 | Initial application for approval in progress | Initial application for approval in progress | No longer supported | No longer supported | |||||||||||||||||||
7a-ethyldihydro-1H,3H,5H-oxazolo[3,4-c]oxazole (EDHO) | 231-810-4 | 7747-35-5 | No longer supported | No longer supported | |||||||||||||||||||||
[1.alpha.(S*),3.alpha.]-(.alpha.)-cyano-(3-phenoxyphenyl)methyl3-(2,2-dichlor-oethenyl)-2,2-dichlorovinyl)-2,2-dimethyl-cyclopropanecarboxylate (alpha-Cypermethrin); [1α(S*),3α]-(α)-cyano-(3-phenoxyphenyl)methyl3-(2,2-dichlor-oethenyl)-2,2-dichlorovinyl)-2,2-dimethyl-cyclopropanecarboxylate αCypermethrin) |
614-054-3 | 67375-30-8 | Approved | ||||||||||||||||||||||
[2,4-Dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1R)-cis-chrysanthemate; [2,4- Dioxo-(2-propyn-1-yl)imidazolidin-3-yl] methyl(1R)-trans-chrysanthemate (Imiprothrin) |
428-790-6 | 72963-72-5 | Approved | ||||||||||||||||||||||
Abamectin | 615-339-5 | 71751-41-2 | Expired | ||||||||||||||||||||||
Acetamiprid | 603-921-1 | 135410-20-7 | Approved | ||||||||||||||||||||||
Legend
-
Initial approval in progressApproved - Renewal in progressApproved - Other update in progress
-
Approved
-
Not approved
-
Expired
-
Cancelled application
-
No longer supported